NURS-FPX 4015 ASSESSMENT
2:HOLISTIC CARE THROUGH
PATHOPHYSIOLOGY &
LATEST MOCK PRACTICE SET
140 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NURS-FPX 4015 ASSESSMENT 2:HOLISTIC CARE THROUGH PATHOPHYSIOLOGY & PHARMACOLOGY |
2026 UPDATE WITH COMPLETE SOLUTIONS - CAPELLA.. It contains 140 carefully selected questions that
reflect the most current exam content and testing strategies. Each question is accompanied by a correct answer
and a detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 140 Questions
Foundations - Application - Nurs-fpx 4015 Assessment 2 Holistic CARE Through Pathophysiology &
Pharmacology 2026 Update WITH Complete Solutions - Capella Pathophysiology & Pharmacology Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Pathophysiology 1-24 Chronic, Explains, Mechanism, Disease, Pathophysiological
Foundations
Pharmacological Principles 25-48 Mechanism, Chronic, Prescribed, Explains, Effect
Cardiovascular Disorders 49-72 Prescribed, Mechanism, Explains, Chronic, Disorder
Respiratory Disorders 73-96 Chronic, Mechanism, Disease, Explains, Effect
Neurological Disorders 97-120 Chronic, Syndrome, Prescribed, Started, Heart
Endocrine Disorders 121-140 Mechanism, Disease, Effect, Chronic, Heart Failure
TOTAL 140 All questions include answers and detailed rationales
,Section A - Pathophysiology Foundations
Q1.
In a patient with chronic heart failure and reduced ejection fraction, which neurohormonal
mechanism is most directly responsible for the maladaptive remodeling that leads to
disease progression despite ACE inhibitor therapy?
A. Sustained activation of the sympathetic B. Compensatory increase in aldosterone
nervous system with downregulation of secretion independent of angiotensin II
beta-1 receptors
C. Overexpression of tumor necrosis D. Increased natriuretic peptide clearance
factor-alpha in the myocardium leading to reduced vasodilation
Correct: B - Compensatory increase in aldosterone secretion independent of angiotensin
II
Rationale:Aldosterone breakthrough occurs in up to 40% of patients on ACE inhibitors,
promoting fibrosis and remodeling. Sympathetic activation is blunted by ACE inhibitors but not
fully, yet aldosterone escape is a key mechanism of progression. TNF-alpha is involved but
not the primary driver. Natriuretic peptide clearance is not the main maladaptive mechanism.
Q2.
A patient with type 2 diabetes and chronic kidney disease (eGFR 32 mL/min) is started on
metformin. Which pharmacological consideration is most critical in this context?
A. Metformin is contraindicated due to risk of B. Dose adjustment is required, and renal
lactic acidosis at this eGFR function must be monitored every 3 months
C. Metformin should be stopped because it D. Metformin is safe without adjustment as it
worsens renal function is not renally cleared
Correct: B - Dose adjustment is required, and renal function must be monitored every 3
months
Rationale:Current guidelines allow metformin use down to eGFR 30 mL/min with dose
reduction. Lactic acidosis risk is low but requires monitoring. Metformin does not worsen renal
function. It is renally cleared, so adjustment is needed.
Q3.
Which pathophysiological mechanism best explains the development of
antibiotic-associated pseudomembranous colitis?
Page 3
, Section A - Pathophysiology Foundations
A. Direct toxin damage to colonic epithelial B. Overgrowth of Clostridium difficile due to
cells by Clostridium difficile, leading to disruption of normal gut flora, producing
inflammation and pseudomembrane toxins that cause mucosal injury
formation
C. Immune-mediated hypersensitivity D. Ischemic injury to the colon resulting from
reaction to antibiotics causing colonic antibiotic-induced vasoconstriction
inflammation
Correct: B - Overgrowth of Clostridium difficile due to disruption of normal gut flora,
producing toxins that cause mucosal injury
Rationale:Antibiotics disrupt normal flora, allowing C. difficile overgrowth; its toxins (A and B)
cause mucosal damage and pseudomembranes. Direct toxin damage without preceding flora
disruption is not the full mechanism. Hypersensitivity and ischemia are not primary.
Q4.
A patient on a stable dose of warfarin is started on a short course of
trimethoprim-sulfamethoxazole. What is the most likely pharmacokinetic interaction and
its clinical consequence?
A. Inhibition of CYP2C9 leading to increased B. Induction of CYP2C9 leading to
warfarin levels and bleeding risk decreased warfarin levels and thrombosis
risk
C. Displacement of warfarin from protein D. Reduced absorption of warfarin due to
binding causing transient increase in INR gastrointestinal effects of the antibiotic
Correct: A - Inhibition of CYP2C9 leading to increased warfarin levels and bleeding risk
Rationale:Trimethoprim-sulfamethoxazole inhibits CYP2C9, the enzyme that metabolizes the
S-enantiomer of warfarin, potentiating its effect and increasing bleeding risk. It does not
induce CYP2C9. Protein binding displacement is minor and not the primary mechanism.
Reduced absorption is not significant.
Q5.
In a patient with septic shock requiring vasopressor support, which combination of
pathophysiological derangements and pharmacological action is most accurate?
A. Distributive shock with profound B. Cardiogenic shock with reduced cardiac
vasodilation; norepinephrine acts primarily output; norepinephrine increases
on alpha-1 receptors to restore vascular contractility via beta-1 stimulation
tone
C. Hypovolemic shock from capillary leak; D. Obstructive shock due to pulmonary
norepinephrine retains fluid by activating embolism; norepinephrine dissolves the clot
aldosterone by activating fibrinolysis
Page 4
2:HOLISTIC CARE THROUGH
PATHOPHYSIOLOGY &
LATEST MOCK PRACTICE SET
140 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NURS-FPX 4015 ASSESSMENT 2:HOLISTIC CARE THROUGH PATHOPHYSIOLOGY & PHARMACOLOGY |
2026 UPDATE WITH COMPLETE SOLUTIONS - CAPELLA.. It contains 140 carefully selected questions that
reflect the most current exam content and testing strategies. Each question is accompanied by a correct answer
and a detailed rationale that explains the underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 140 Questions
Foundations - Application - Nurs-fpx 4015 Assessment 2 Holistic CARE Through Pathophysiology &
Pharmacology 2026 Update WITH Complete Solutions - Capella Pathophysiology & Pharmacology Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Pathophysiology 1-24 Chronic, Explains, Mechanism, Disease, Pathophysiological
Foundations
Pharmacological Principles 25-48 Mechanism, Chronic, Prescribed, Explains, Effect
Cardiovascular Disorders 49-72 Prescribed, Mechanism, Explains, Chronic, Disorder
Respiratory Disorders 73-96 Chronic, Mechanism, Disease, Explains, Effect
Neurological Disorders 97-120 Chronic, Syndrome, Prescribed, Started, Heart
Endocrine Disorders 121-140 Mechanism, Disease, Effect, Chronic, Heart Failure
TOTAL 140 All questions include answers and detailed rationales
,Section A - Pathophysiology Foundations
Q1.
In a patient with chronic heart failure and reduced ejection fraction, which neurohormonal
mechanism is most directly responsible for the maladaptive remodeling that leads to
disease progression despite ACE inhibitor therapy?
A. Sustained activation of the sympathetic B. Compensatory increase in aldosterone
nervous system with downregulation of secretion independent of angiotensin II
beta-1 receptors
C. Overexpression of tumor necrosis D. Increased natriuretic peptide clearance
factor-alpha in the myocardium leading to reduced vasodilation
Correct: B - Compensatory increase in aldosterone secretion independent of angiotensin
II
Rationale:Aldosterone breakthrough occurs in up to 40% of patients on ACE inhibitors,
promoting fibrosis and remodeling. Sympathetic activation is blunted by ACE inhibitors but not
fully, yet aldosterone escape is a key mechanism of progression. TNF-alpha is involved but
not the primary driver. Natriuretic peptide clearance is not the main maladaptive mechanism.
Q2.
A patient with type 2 diabetes and chronic kidney disease (eGFR 32 mL/min) is started on
metformin. Which pharmacological consideration is most critical in this context?
A. Metformin is contraindicated due to risk of B. Dose adjustment is required, and renal
lactic acidosis at this eGFR function must be monitored every 3 months
C. Metformin should be stopped because it D. Metformin is safe without adjustment as it
worsens renal function is not renally cleared
Correct: B - Dose adjustment is required, and renal function must be monitored every 3
months
Rationale:Current guidelines allow metformin use down to eGFR 30 mL/min with dose
reduction. Lactic acidosis risk is low but requires monitoring. Metformin does not worsen renal
function. It is renally cleared, so adjustment is needed.
Q3.
Which pathophysiological mechanism best explains the development of
antibiotic-associated pseudomembranous colitis?
Page 3
, Section A - Pathophysiology Foundations
A. Direct toxin damage to colonic epithelial B. Overgrowth of Clostridium difficile due to
cells by Clostridium difficile, leading to disruption of normal gut flora, producing
inflammation and pseudomembrane toxins that cause mucosal injury
formation
C. Immune-mediated hypersensitivity D. Ischemic injury to the colon resulting from
reaction to antibiotics causing colonic antibiotic-induced vasoconstriction
inflammation
Correct: B - Overgrowth of Clostridium difficile due to disruption of normal gut flora,
producing toxins that cause mucosal injury
Rationale:Antibiotics disrupt normal flora, allowing C. difficile overgrowth; its toxins (A and B)
cause mucosal damage and pseudomembranes. Direct toxin damage without preceding flora
disruption is not the full mechanism. Hypersensitivity and ischemia are not primary.
Q4.
A patient on a stable dose of warfarin is started on a short course of
trimethoprim-sulfamethoxazole. What is the most likely pharmacokinetic interaction and
its clinical consequence?
A. Inhibition of CYP2C9 leading to increased B. Induction of CYP2C9 leading to
warfarin levels and bleeding risk decreased warfarin levels and thrombosis
risk
C. Displacement of warfarin from protein D. Reduced absorption of warfarin due to
binding causing transient increase in INR gastrointestinal effects of the antibiotic
Correct: A - Inhibition of CYP2C9 leading to increased warfarin levels and bleeding risk
Rationale:Trimethoprim-sulfamethoxazole inhibits CYP2C9, the enzyme that metabolizes the
S-enantiomer of warfarin, potentiating its effect and increasing bleeding risk. It does not
induce CYP2C9. Protein binding displacement is minor and not the primary mechanism.
Reduced absorption is not significant.
Q5.
In a patient with septic shock requiring vasopressor support, which combination of
pathophysiological derangements and pharmacological action is most accurate?
A. Distributive shock with profound B. Cardiogenic shock with reduced cardiac
vasodilation; norepinephrine acts primarily output; norepinephrine increases
on alpha-1 receptors to restore vascular contractility via beta-1 stimulation
tone
C. Hypovolemic shock from capillary leak; D. Obstructive shock due to pulmonary
norepinephrine retains fluid by activating embolism; norepinephrine dissolves the clot
aldosterone by activating fibrinolysis
Page 4
